好酸球性食道炎の成人および青年患者におけるCC-93538の有効性と安全性を評価する研究

基本情報

NCT ID

NCT04753697

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

430

治験依頼者名

Celgene

概要

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evaluate the efficacy and safety of CC- 93538 in adult and adolescent participants with eosinophilic esophagitis (EoE). The study will incorporate a 24-week Induction Phase followed by a 24-week Maintenance Phase. Participants will be randomized at the beginning of the study into 3 treatment arms: * Placebo for Induction and Maintenance * CC-93538 360 mg Subcutaneous (SC) once weekly for Induction followed by 360 mg SC once every other week for Maintenance * CC-93538 360 mg SC once weekly for Induction and Maintenance

対象疾患

介入

依頼者（Sponsor）